{"id":12350,"date":"2021-09-20T17:05:49","date_gmt":"2021-09-20T08:05:49","guid":{"rendered":"https:\/\/microncro.com\/?post_type=resources&#038;p=12350"},"modified":"2026-06-12T15:53:14","modified_gmt":"2026-06-12T06:53:14","slug":"video_cde_guidance_and_fda_guidance","status":"publish","type":"resources","link":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/","title":{"rendered":"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints"},"content":{"rendered":"<figure style=\"width:455px;\" class=\"aligncenter wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"517\" src=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png 1024w, https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1-768x388.png 768w, https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1-410x207.png 410w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n<p class=\"is-small-size\">In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.<br>Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.<br>In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on antitumor clinical trials.<br>In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.<\/p>\n\n\n\n<p class=\"is-small-size\">Video: Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized is-caption-center\"><a href=\"https:\/\/www.youtube.com\/watch?v=kDaJDCRCiZM&amp;feature=youtu.be\"><img loading=\"lazy\" decoding=\"async\" width=\"986\" height=\"530\" src=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/66c19942ab4ba346fdb64ccc04cde373.png\" alt=\"CDE Guidance\" class=\"wp-image-12351\" style=\"width:980px\" srcset=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/66c19942ab4ba346fdb64ccc04cde373.png 986w, https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/66c19942ab4ba346fdb64ccc04cde373-768x413.png 768w\" sizes=\"auto, (max-width: 986px) 100vw, 986px\" \/><\/a><figcaption class=\"wp-element-caption is-caption-center\">Click on the image<\/figcaption><\/figure>\n<\/div>\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button is-dark-color is-large-size\" href=\"https:\/\/microncro.com\/en\/resources\/\">View Resources<\/a><\/div>\n\n\n\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button is-dark-color is-large-size\" href=\"https:\/\/microncro.com\/en\/contact\/\">Contact Us<\/a><\/div>\n<\/div>\n\n\n\n\n<div class=\"micron-share\">\n\t<div class=\"micron-share-inner\">\n\t\t<h2 class=\"micron-share-title\">Share<\/h2>\n\t\t<ul class=\"micron-share-buttons\">\n\t\t\t<li><a class=\"micron-share-button-linkedin\" href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/\" rel=\"nofollow\" target=\"_blank\">LinkedIn \u3067\u30b7\u30a7\u30a2\u3059\u308b<\/a><\/li>\n\t\t<\/ul>\n\t<\/div>\n<\/div>\n","protected":false},"featured_media":12374,"menu_order":15,"template":"","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/microncro.com\/?post_type=resources&p=12350","footnotes":""},"content-type":[8],"service":[10],"keyword":[],"class_list":["post-12350","resources","type-resources","status-publish","has-post-thumbnail","hentry","en-US"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.<\/title>\n<meta name=\"description\" content=\"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.\" \/>\n<meta property=\"og:description\" content=\"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/\" \/>\n<meta property=\"og:site_name\" content=\"Micron, Inc.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-12T06:53:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"517\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/\",\"name\":\"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/36_thumb_video-2-1024x517-1.png\",\"datePublished\":\"2021-09-20T08:05:49+00:00\",\"dateModified\":\"2026-06-12T06:53:14+00:00\",\"description\":\"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/36_thumb_video-2-1024x517-1.png\",\"contentUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/36_thumb_video-2-1024x517-1.png\",\"width\":1024,\"height\":517},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/resources\\\/video_cde_guidance_and_fda_guidance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/microncro.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u30e9\u30a4\u30d6\u30e9\u30ea\",\"item\":\"https:\\\/\\\/microncro.com\\\/resources\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"description\":\"Molecular Imaging CRO Network\",\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/microncro.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"contentUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"width\":1200,\"height\":630,\"caption\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\"},\"image\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.","description":"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/","og_locale":"en_US","og_type":"article","og_title":"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.","og_description":"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.","og_url":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/","og_site_name":"Micron, Inc.","article_modified_time":"2026-06-12T06:53:14+00:00","og_image":[{"width":1024,"height":517,"url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/","url":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/","name":"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints - Micron, Inc.","isPartOf":{"@id":"https:\/\/microncro.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/#primaryimage"},"image":{"@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png","datePublished":"2021-09-20T08:05:49+00:00","dateModified":"2026-06-12T06:53:14+00:00","description":"In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.","breadcrumb":{"@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/#primaryimage","url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png","contentUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png","width":1024,"height":517},{"@type":"BreadcrumbList","@id":"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microncro.com\/en\/"},{"@type":"ListItem","position":2,"name":"\u30e9\u30a4\u30d6\u30e9\u30ea","item":"https:\/\/microncro.com\/resources\/"},{"@type":"ListItem","position":3,"name":"Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints"}]},{"@type":"WebSite","@id":"https:\/\/microncro.com\/#website","url":"https:\/\/microncro.com\/","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","description":"Molecular Imaging CRO Network","publisher":{"@id":"https:\/\/microncro.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microncro.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microncro.com\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","url":"https:\/\/microncro.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/","url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","contentUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","width":1200,"height":630,"caption":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3"},"image":{"@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/resources\/12350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":20,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/resources\/12350\/revisions"}],"predecessor-version":[{"id":16157,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/resources\/12350\/revisions\/16157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/media\/12374"}],"wp:attachment":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/media?parent=12350"}],"wp:term":[{"taxonomy":"content-type","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/content-type?post=12350"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/service?post=12350"},{"taxonomy":"keyword","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/keyword?post=12350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}